Clinical and Patient-Reported Outcomes of Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C Among Patients on Opioid Agonist Treatment: A Real-world Prospective Cohort Study

Patient-reported outcomes (PROs) can help to reduce uncertainties about hepatitis C virus (HCV) treatment with direct-acting antivirals (DAAs) among people who inject drugs and increase treatment uptake in this high-risk group. Besides clinical data, this study analyzed for the first time PROs in a...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Open Forum Infectious Diseases 2020-08, Vol.7 (8), p.ofaa317-ofaa317
Hauptverfasser:	Schulte, Bernd, Schmidt, Christiane S, Manthey, Jakob, Strada, Lisa, Christensen, Stefan, Cimander, Konrad, Görne, Herbert, Khaykin, Pavel, Scherbaum, Norbert, Walcher, Stefan, Mauss, Stefan, Schäfer, Ingo, Verthein, Uwe, Rehm, Jürgen, Reimer, Jens
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral agents Hepatitis C virus Major Patient compliance Pharmaceutical industry
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!